• Posted: December 4, 2018 ASH 2018 Day 3 - Therapy, excluding Transplantation: Antibodies and Targeted...

    READ MORE
  • Posted: December 4, 2018 ASH 2018 Day 3 - Immunotherapy

    READ MORE
  • Posted: December 3, 2018 Ash 2018 Day 2 - CoMMpass Oral Presentations

    READ MORE
  • Posted: December 1, 2018 The MMRF CoMMpass Study Drives New Discoveries in Multiple Myeloma

    READ MORE
  • Posted: November 13, 2018 Precision Medicine Has Transformed Cancer Treatment. Here’s How to Move It...

    READ MORE
  • Posted: November 1, 2018 Verily Advisory Board Series: Kathy Giusti on driving change for better health

    READ MORE
  • Posted: October 31, 2018 Breakthrough in Immunotherapy and Myeloma Prevention

    READ MORE
  • Posted: September 28, 2018 FDA Grants De Novo Designation for Adaptive Biotechnologies’ clonoSEQ Assay...

    READ MORE
  • Posted: September 28, 2018 2018 MRD Meeting in NYC

    READ MORE
  • Posted: September 11, 2018 San Diego Myeloma 2018 Day 2

    READ MORE

Page 1/4